Skip to main content
Journal cover image

Neurocognitive Effects of Combined Electroconvulsive Therapy (ECT) and Venlafaxine in Geriatric Depression: Phase 1 of the PRIDE Study.

Publication ,  Journal Article
Lisanby, SH; McClintock, SM; Alexopoulos, G; Bailine, SH; Bernhardt, E; Briggs, MC; Cullum, CM; Deng, Z-D; Dooley, M; Geduldig, ET; Husain, MM ...
Published in: Am J Geriatr Psychiatry
March 2020

OBJECTIVE: There is limited information regarding the tolerability of electroconvulsive therapy (ECT) combined with pharmacotherapy in elderly adults with major depressive disorder (MDD). Addressing this gap, we report acute neurocognitive outcomes from Phase 1 of the Prolonging Remission in Depressed Elderly (PRIDE) study. METHODS: Elderly adults (age ≥60) with MDD received an acute course of 6 times seizure threshold right unilateral ultrabrief pulse (RUL-UB) ECT. Venlafaxine was initiated during the first treatment week and continued throughout the study. A comprehensive neurocognitive battery was administered at baseline and 72 hours following the last ECT session. Statistical significance was defined as a two-sided p-value of less than 0.05. RESULTS: A total of 240 elderly adults were enrolled. Neurocognitive performance acutely declined post ECT on measures of psychomotor and verbal processing speed, autobiographical memory consistency, short-term verbal recall and recognition of learned words, phonemic fluency, and complex visual scanning/cognitive flexibility. The magnitude of change from baseline to end for most neurocognitive measures was modest. CONCLUSION: This is the first study to characterize the neurocognitive effects of combined RUL-UB ECT and venlafaxine in elderly adults with MDD and provides new evidence for the tolerability of RUL-UB ECT in an elderly sample. Of the cognitive domains assessed, only phonemic fluency, complex visual scanning, and cognitive flexibility qualitatively declined from low average to mildly impaired. While some acute changes in neurocognitive performance were statistically significant, the majority of the indices as based on the effect sizes remained relatively stable.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Am J Geriatr Psychiatry

DOI

EISSN

1545-7214

Publication Date

March 2020

Volume

28

Issue

3

Start / End Page

304 / 316

Location

England

Related Subject Headings

  • Venlafaxine Hydrochloride
  • Treatment Outcome
  • Neuropsychological Tests
  • Neurocognitive Disorders
  • Male
  • Humans
  • Geriatrics
  • Female
  • Electroconvulsive Therapy
  • Depressive Disorder, Major
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Lisanby, S. H., McClintock, S. M., Alexopoulos, G., Bailine, S. H., Bernhardt, E., Briggs, M. C., … CORE/PRIDE Work Group. (2020). Neurocognitive Effects of Combined Electroconvulsive Therapy (ECT) and Venlafaxine in Geriatric Depression: Phase 1 of the PRIDE Study. Am J Geriatr Psychiatry, 28(3), 304–316. https://doi.org/10.1016/j.jagp.2019.10.003
Lisanby, Sarah H., Shawn M. McClintock, George Alexopoulos, Samuel H. Bailine, Elisabeth Bernhardt, Mimi C. Briggs, C Munro Cullum, et al. “Neurocognitive Effects of Combined Electroconvulsive Therapy (ECT) and Venlafaxine in Geriatric Depression: Phase 1 of the PRIDE Study.Am J Geriatr Psychiatry 28, no. 3 (March 2020): 304–16. https://doi.org/10.1016/j.jagp.2019.10.003.
Lisanby SH, McClintock SM, Alexopoulos G, Bailine SH, Bernhardt E, Briggs MC, et al. Neurocognitive Effects of Combined Electroconvulsive Therapy (ECT) and Venlafaxine in Geriatric Depression: Phase 1 of the PRIDE Study. Am J Geriatr Psychiatry. 2020 Mar;28(3):304–16.
Lisanby, Sarah H., et al. “Neurocognitive Effects of Combined Electroconvulsive Therapy (ECT) and Venlafaxine in Geriatric Depression: Phase 1 of the PRIDE Study.Am J Geriatr Psychiatry, vol. 28, no. 3, Mar. 2020, pp. 304–16. Pubmed, doi:10.1016/j.jagp.2019.10.003.
Lisanby SH, McClintock SM, Alexopoulos G, Bailine SH, Bernhardt E, Briggs MC, Cullum CM, Deng Z-D, Dooley M, Geduldig ET, Greenberg RM, Husain MM, Kaliora S, Knapp RG, Latoussakis V, Liebman LS, McCall WV, Mueller M, Petrides G, Prudic J, Rosenquist PB, Rudorfer MV, Sampson S, Teklehaimanot AA, Tobias KG, Weiner RD, Young RC, Kellner CH, CORE/PRIDE Work Group. Neurocognitive Effects of Combined Electroconvulsive Therapy (ECT) and Venlafaxine in Geriatric Depression: Phase 1 of the PRIDE Study. Am J Geriatr Psychiatry. 2020 Mar;28(3):304–316.
Journal cover image

Published In

Am J Geriatr Psychiatry

DOI

EISSN

1545-7214

Publication Date

March 2020

Volume

28

Issue

3

Start / End Page

304 / 316

Location

England

Related Subject Headings

  • Venlafaxine Hydrochloride
  • Treatment Outcome
  • Neuropsychological Tests
  • Neurocognitive Disorders
  • Male
  • Humans
  • Geriatrics
  • Female
  • Electroconvulsive Therapy
  • Depressive Disorder, Major